Age: 20.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Intensive care, Peripheral artery thrombosis, Pulmonary embolism, Subclavian vein thrombosis, Thrombolysis
Clinical narrative: blood clot that went into her lungs; blood clot in her right shoulder, blood clot that went into her lungs , has thrombosis; is in pain and suffering; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clot in her right shoulder, blood clot that went into her lungs , has thrombosis) and PULMONARY EMBOLISM (blood clot that went into her lungs) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (first two doses were Pfizer, no reaction at all and completed 6 months ago). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE.    On 09-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2022, the patient experienced THROMBOSIS (blood clot in her right shoulder, blood clot that went into her lungs , has thrombosis) (seriousness criteria hospitalization, medically significant and life threatening). On an unknown date, the patient experienced PULMONARY EMBOLISM (blood clot that went into her lungs) (seriousness criteria hospitalization and life threatening) and PAIN (is in pain and suffering). The patient was hospitalized for 3 days due to THROMBOSIS. At the time of the report, THROMBOSIS (blood clot in her right shoulder, blood clot that went into her lungs , has thrombosis), PULMONARY EMBOLISM (blood clot that went into her lungs) and PAIN (is in pain and suffering) outcome was unknown.            Concomitant medications were not reported.  Patient had Moderna booster two days ago, now she got blood clot in her right shoulder. Upon clarification, blood clot developed today. Per caller, her daughter was healthy before this. Patient was in ER right now at the time of the call. Doctor gave blood thinner for treatment. Per caller, patient's first two doses were Pfizer, no reaction at all, completed 6 months ago.  Blood clot was in her right shoulder. Patient was not on any long-term medication, no medical condition prior to this. Patient was not pregnant. Hospital for treatment. Patient also heard about reports of blood clots in elsewhere. it was reported that the patient had a blood clot that went into her lungs, she has been on blood thinners for 3 nights, and in the hospital for 3 days now. She had thrombosis, she was in pain and suffering. Company comment: This is Spontaneous case concerns a 20-year-old, female patient, with no reported medical history, who experienced the unexpected, serious (Life threatening/Hospitalization/ Medically significant) and AESI of Thrombosis and pulmonary embolism. The events occurred 2 days after receiving a dose of mRNA-1273 vaccine, considered as the third dose of the patient's COVID-19 vaccination schedule. It was reported that the patient was treated with blood thinners for three days. All the events could be in connection with each other. The patient received as first and second dose of her COVID-19 vaccination schedule two doses Pfizer's COVID-19 vaccine 6 months prior. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jan-2022: Follow-up received - Event Pain added , Serious criteria for event Thrombosis updated; Sender's Comments: This is Spontaneous case concerns a 20-year-old, female patient, with no reported medical history, who experienced the unexpected, serious (Life threatening/Hospitalization/ Medically significant) and AESI of Thrombosis and pulmonary embolism. The events occurred 2 days after receiving a dose of mRNA-1273 vaccine, considered as the third dose of the patient's COVID-19 vaccination schedule. It was reported that the patient was treated with blood thinners for three days. All the events could be in connection with each other. The patient received as first and second dose of her COVID-19 vaccination schedule two doses Pfizer's COVID-19 vaccine 6 months prior. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.